General Information
Version
US Page 1 of 11
Revision date
2024-02-13
Product name
Human MBNL1 kit Standard 63ADK012CDA
1.2.1 Relevant identified uses
Use of the substance or mixture for Laboratory Research use only ;
1.2.2. Uses advised against
Do not use for diagnostics, therapeutics or other clinical uses. ;
supplier name
Revvity Health Sciences, Inc.
Emergency telephone
France - Numéro ORFILA (INRS) : + 33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
Revvity Health Sciences, Inc.
e-mail address of the competent person responsible for the Safety Data Sheet
codolet.sds@revvity.com
GHS Information
Signal word
Hazard
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification in accordance with
Precautionary statements
HCS) The substance or mixture is not classified as hazardous in accordance with
2.2 Label elements
Labelling according to Hazard Communication Standard (HCS) (29 CFR 1910.1200(g))
Product definition
Designation / Trade name: Human MBNL1 kit Standard 63ADK012CDA Substances contained in this product: Version US Page 2 of 11 Revision Date: 13/02/2024
Signal word
Hazard and precautionary statements:
2.3 Other hazards
The mixture does not contain substances classified as ‘Substances of Very High Concern' (SVHC) >= 0.1% published by the European CHemicals Agency (ECHA) under article 57 of REACH. The mixture satisfies neither the PBT nor the vPvB criteria for mixtures in accordance with annexe XIII of the REACH regulations EC
Potential health effects
Version US Page 3 of 11 Revision Date: 13/02/2024
